Facts and myths on recurrent vulvovaginal candidosis--a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy.
about
Study of the prevalence and association of ocular chlamydial conjunctivitis in women with genital infection by Chlamydia trachomatis, Mycoplasma genitalium and Candida albicans attending outpatient clinicScanning electron and confocal scanning laser microscopy imaging of the ultrastructure and viability of vaginal Candida albicans and non- albicans species adhered to an intrauterine contraceptive device.Chronic vulvar irritation: could toilet paper be the culprit?The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective.Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasisRecurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices.What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based surveyHighly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique databaseLeukocyte esterase activity in vaginal fluid of pregnant and non-pregnant women with vaginitis/vaginosis and in controlsIn vitro anti-Candida activity of lidocaine and nitroglycerin: alone and combined.Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in IndiaHistory and update on host defense against vaginal candidiasis.Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasisSubjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USAFixed drug eruption resulting from fluconazole use: a case report.Detection of FUR1 Gene in 5-Flucytosine Resistant Candida Isolates in Vaginal Candidiasis Patients.Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal.Vaginal thrush: quality of life and treatments.Ultrastructural imaging of Candida albicans adhesion to rat genital epithelium through scanning and transmission electron microscopy.Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis.Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: comparison of a 1-day and a 3-day regimen.In vitro Assessment of Gentian Violet Anti-CandidaActivityAssociation of gestational diabetes mellitus and abnormal vaginal flora with adverse pregnancy outcomes
P2860
Q28829686-6EE686F4-4AD3-41D1-8A5A-89C46E82F7FCQ33678346-01D95220-7963-4C3B-9343-29817C220220Q33815314-D9F6B8D3-847F-4AEC-AB44-AFCB17446930Q34186380-4F08E5F7-FC54-4D7C-875E-6669A2D3BE23Q34229783-FAE35FA0-3053-4606-80F6-79E63250FA96Q34458966-7EE547C7-62AC-4ABE-9896-DE644F0715A0Q34785676-039A2A6D-7A9D-436B-9B08-6E76EFB7171BQ35115653-82716D6C-083C-44BF-B559-7E8C02CC34FDQ35614553-B32A9D0A-4139-4E54-9E5F-3FB14665C222Q35614584-0D373CF3-86A6-4291-9056-130326042A18Q35751140-2750F72A-DEDE-4B69-A1AC-E61DBAB3DC43Q35997689-7334724A-97B0-420C-AB62-57E41C148E23Q36340226-73673993-F99C-4286-AFA0-7F86E8A5F66CQ36677660-267A7F24-E830-4DAB-903C-CF7967105DFAQ36850886-55FE57D9-83BA-44D0-AD38-E38A3B0C1C69Q36877951-39FA4851-E490-45EA-ADB7-C7EAB533C23CQ37274301-ACC5B7E3-89E5-4A9B-A5CB-A956480F31E9Q37332932-88D30643-18A9-4AE0-90BC-9ECB60925BA5Q37429419-74C5FC20-4220-4F55-A64B-F70C356CEFA4Q39506915-4F347E4B-07A6-4337-8354-8088D2F0C5E5Q41588595-F2A378E0-B3F7-46B1-A7B2-A2DABF4ED7B2Q42876396-1F6CC160-9E13-48C4-BD71-3E05351636EDQ44662628-E1BBDD9F-FBF3-41F0-BA9B-40603CF0A3DBQ46433663-D91D717B-F75B-433D-825A-A0B2766DB042Q46447085-6FD1F842-9AFF-4890-9E71-0839451CFE0EQ56988745-4080E52B-6BD2-49BD-B4D4-BC77603926FDQ58706857-94B4AE3B-04C8-413E-8899-024B727FABD3
P2860
Facts and myths on recurrent vulvovaginal candidosis--a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@en
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@nl
type
label
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@en
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@nl
prefLabel
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@en
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@nl
P2093
P1476
Facts and myths on recurrent v ...... sis, pathogenesis and therapy.
@en
P2093
Acacio G Rodrigues
J Martinez-de-Oliveira
Mehmet Genç
Natalia Novikova
Per-Anders Mårdh
Secondo Guaschino
P304
P356
10.1258/095646202760159639
P577
2002-08-01T00:00:00Z